Thomasville National Bank Gilead Sciences, Inc. Transaction History

Thomasville National Bank

$1.3 Billion
Q3 2024

A detailed history of Thomasville National Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Thomasville National Bank holds 192,152 shares of GILD stock, worth $17.6 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares

192,152

Previous 179,201 7.23%

Holding current value

$17.6 Million

Previous $12.3 Million 31.01%

% of portfolio

1.24%

Previous 1.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$66.59 - $83.99 $862,407 - $1.09 Million	12,951 Added 7.23%	192,152 $16.1 Million
Q2 2024 Jul 10, 2024	BUY	$63.15 - $72.88 $701,091 - $809,113	11,102 Added 6.6%	179,201 $12.3 Million
Q1 2024 Apr 10, 2024	BUY	$71.58 - $87.29 $860,821 - $1.05 Million	12,026 Added 7.71%	168,099 $12.3 Million
Q4 2023 Jan 11, 2024	BUY	$73.27 - $83.09 $257,250 - $291,728	3,511 Added 2.3%	156,073 $12.6 Million
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $223,150 - $243,462	3,018 Added 2.02%	152,562 $11.4 Million
Q2 2023 Jul 10, 2023	BUY	$76.01 - $86.7 $361,047 - $411,825	4,750 Added 3.28%	149,544 $11.5 Million
Q1 2023 Apr 10, 2023	BUY	$77.31 - $88.08 $3,324 - $3,787	43 Added 0.03%	144,794 $12 Million
Q4 2022 Jan 10, 2023	SELL	$62.32 - $89.47 $356,470 - $511,768	-5,720 Reduced 3.8%	144,751 $12.4 Million
Q3 2022 Oct 03, 2022	BUY	$59.54 - $68.01 $376,352 - $429,891	6,321 Added 4.39%	150,471 $9.28 Million
Q2 2022 Jul 28, 2022	BUY	$57.72 - $65.01 $316,190 - $356,124	5,478 Added 3.95%	144,150 $8.91 Million
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $376,943 - $472,350	6,508 Added 4.92%	138,672 $8.24 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $541,358 - $614,452	8,344 Added 6.74%	132,164 $9.6 Million
Q3 2021 Oct 04, 2021	BUY	$67.69 - $73.03 $479,312 - $517,125	7,081 Added 6.07%	123,820 $8.65 Million
Q2 2021 Jul 02, 2021	SELL	$63.47 - $69.35 $1.83 Million - $1.99 Million	-28,761 Reduced 19.77%	116,739 $8.04 Million
Q1 2021 Apr 01, 2021	BUY	$60.0 - $68.46 $2.84 Million - $3.24 Million	47,384 Added 48.29%	145,500 $10.9 Million
Q4 2020 Jan 04, 2021	SELL	$56.65 - $64.55 $2.54 Million - $2.89 Million	-44,768 Reduced 31.33%	98,116 $5.72 Million
Q3 2020 Oct 01, 2020	SELL	$62.1 - $78.08 $87,623 - $110,170	-1,411 Reduced 0.98%	142,884 $9.03 Million
Q2 2020 Jul 01, 2020	BUY	$72.34 - $84.0 $10.4 Million - $12.1 Million	144,295 New	144,295 $11.1 Million
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $161,278 - $210,456	-2,664 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $13,543 - $14,994	-190 Reduced 6.66%	2,664 $206,000
Q2 2018 Jul 11, 2018	BUY	$64.88 - $75.68 $5,190 - $6,054	80 Added 2.88%	2,854 $202,000
Q1 2018 Apr 20, 2018	BUY	$72.84 - $88.8 $202,058 - $246,331	2,774 New	2,774 $209,000
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $263,397 - $309,191	-3,702 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $266,951 - $316,409	3,702	3,702 $300,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.

Account

Thomasville National Bank Gilead Sciences, Inc. Transaction History